Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1.
Gao Q, Deng H, Yang Z, Yang Q, Zhang Y, Yuan X, Zeng M, Guo M, Zeng W, Jiang X, Yu B.
Gao Q, et al. Among authors: zeng m, zeng w.
Front Pharmacol. 2022 Sep 15;13:946668. doi: 10.3389/fphar.2022.946668. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36188542
Free PMC article.